| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Kck Ltd. is a 10% Owner at SGHT with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 35 sells.
Estimated insider holdings value: $26.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 20, 2025 | NPCE Neuropace Inc | 10% Owner | Sell | 5,270,845 | $9.40 | $49,545,943.00 | -100% | +27.4% | +0.8% | |
| Oct 25, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 224,138 | $5.45 | $1,221,927.08 | -2.0% | +120.8% | +65.0% | |
| Oct 22, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 4,082 | $6.09 | $24,853.26 | - | +117.7% | +80.7% | |
| Oct 21, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 8,598 | $6.21 | $53,370.50 | - | +110.6% | +74.0% | |
| Oct 17, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 46,426 | $6.53 | $303,366.79 | - | +87.8% | +62.9% | |
| Oct 2, 2024 | NPCE Neuropace Inc | 10% Owner | Sell | 39,684 | $6.92 | $274,713.90 | - | +61.5% | +50.5% | |
| Dec 1, 2023 | NPCE Neuropace Inc | 10% Owner | Sell | 16,167 | $8.78 | $141,882.49 | - | +81.7% | +19.1% | |
| Nov 28, 2023 | NPCE Neuropace Inc | 10% Owner | Sell | 11,171 | $8.87 | $99,109.15 | - | +93.7% | +17.1% | |
| Jul 5, 2017 | RNTX Rein Therapeutics, Inc. | 10% Owner | Buy | 200,000 | $15.00 | $3,000,000.00 | +44.8% | - | - |